337 related articles for article (PubMed ID: 20815175)
1. [Sirtuins--modulation of their activity as a novel therapeutic target].
Kucińska M; Piotrowska H; Murias M
Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin inhibitors.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
[TBL] [Abstract][Full Text] [Related]
3. [Sirtuins--way to longevity or just a fad?].
Kucińska M; Murias M
Pol Merkur Lekarski; 2010 Feb; 28(164):158-61. PubMed ID: 20369747
[TBL] [Abstract][Full Text] [Related]
4. Neuronal protection by sirtuins in Alzheimer's disease.
Anekonda TS; Reddy PH
J Neurochem; 2006 Jan; 96(2):305-13. PubMed ID: 16219030
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
Aljada A; Dong L; Mousa SA
Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins.
Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y
Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720
[TBL] [Abstract][Full Text] [Related]
7. Acetate metabolism and aging: An emerging connection.
Shimazu T; Hirschey MD; Huang JY; Ho LT; Verdin E
Mech Ageing Dev; 2010; 131(7-8):511-6. PubMed ID: 20478325
[TBL] [Abstract][Full Text] [Related]
8. Sirtuins and p53.
van Leeuwen I; Lain S
Adv Cancer Res; 2009; 102():171-95. PubMed ID: 19595309
[TBL] [Abstract][Full Text] [Related]
9. Sirtuins in cognitive ageing and Alzheimer's disease.
Braidy N; Jayasena T; Poljak A; Sachdev PS
Curr Opin Psychiatry; 2012 May; 25(3):226-30. PubMed ID: 22327552
[TBL] [Abstract][Full Text] [Related]
10. The Sirtuin family: therapeutic targets to treat diseases of aging.
Milne JC; Denu JM
Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of activators and inhibitors of sirtuins.
Balcerczyk A; Pirola L
Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
[TBL] [Abstract][Full Text] [Related]
12. Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation.
Engel N; Mahlknecht U
Int J Mol Med; 2008 Feb; 21(2):223-32. PubMed ID: 18204789
[TBL] [Abstract][Full Text] [Related]
13. Sirtuins in aging and age-related disease.
Longo VD; Kennedy BK
Cell; 2006 Jul; 126(2):257-68. PubMed ID: 16873059
[TBL] [Abstract][Full Text] [Related]
14. SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology.
Anastasiou D; Krek W
Physiology (Bethesda); 2006 Dec; 21():404-10. PubMed ID: 17119153
[TBL] [Abstract][Full Text] [Related]
15. The neurobiology of sirtuins and their role in neurodegeneration.
Donmez G
Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331
[TBL] [Abstract][Full Text] [Related]
16. A therapeutic role for sirtuins in diseases of aging?
Westphal CH; Dipp MA; Guarente L
Trends Biochem Sci; 2007 Dec; 32(12):555-60. PubMed ID: 17980602
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
Gan L
Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
[TBL] [Abstract][Full Text] [Related]
18. Seven sirtuins for seven deadly diseases of aging.
Morris BJ
Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
20. Sirtuins: a family of proteins with implications for human performance and exercise physiology.
Lappalainen Z
Res Sports Med; 2011 Jan; 19(1):53-65. PubMed ID: 21253976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
